Middle East & Africa ECMO Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Middle East & Africa ECMO Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa ECMO Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Middle East & Africa ECMO Market Regional Analysis

6.2 Middle East & Africa ECMO Market Revenue 2020-2028 (US$ Million)

6.3 Middle East & Africa ECMO Market Forecast Analysis

7. Middle East & Africa ECMO Market Analysis – by Modality

7.1 Venoarterial ECMO

7.1.1 Overview
7.1.2 Venoarterial ECMO: Middle East & Africa ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Venovenous ECMO

7.2.1 Overview
7.2.2 Venovenous ECMO: Middle East & Africa ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Arteriovenous ECMO

7.3.1 Overview
7.3.2 Arteriovenous ECMO: Middle East & Africa ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Middle East & Africa ECMO Market Analysis – by Application

8.1 Respiratory

8.1.1 Overview
8.1.2 Respiratory: Middle East & Africa ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Cardiology

8.2.1 Overview
8.2.2 Cardiology: Middle East & Africa ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Middle East & Africa ECMO Market Analysis – by Age Group

9.1 Adults

9.1.1 Overview
9.1.2 Adults: Middle East & Africa ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Pediatrics

9.2.1 Overview
9.2.2 Pediatrics: Middle East & Africa ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Neonates

9.3.1 Overview
9.3.2 Neonates : Middle East & Africa ECMO Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Middle East & Africa ECMO Market – Middle East and Africa Analysis

10.1 Overview

10.2 Middle East and Africa

10.2.1 Middle East & Africa ECMO Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 Middle East & Africa ECMO Market – Revenue and Forecast Analysis – by Country
10.2.1.1 South Africa: Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 South Africa: Middle East & Africa ECMO Market Breakdown, by Modality
10.2.1.1.2 South Africa: Middle East & Africa ECMO Market Breakdown, by Application
10.2.1.1.3 South Africa: Middle East & Africa ECMO Market Breakdown, by Age Group

10.2.1.2 Saudi Arabia: Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Saudi Arabia: Middle East & Africa ECMO Market Breakdown, by Modality
10.2.1.2.2 Saudi Arabia: Middle East & Africa ECMO Market Breakdown, by Application
10.2.1.2.3 Saudi Arabia: Middle East & Africa ECMO Market Breakdown, by Age Group

10.2.1.3 UAE: Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 UAE: Middle East & Africa ECMO Market Breakdown, by Modality
10.2.1.3.2 UAE: Middle East & Africa ECMO Market Breakdown, by Application
10.2.1.3.3 UAE: Middle East & Africa ECMO Market Breakdown, by Age Group

10.2.1.4 Rest of Middle East and Africa: Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa ECMO Market Breakdown, by Modality
10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa ECMO Market Breakdown, by Application
10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa ECMO Market Breakdown, by Age Group

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 ABIOMED Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Braile Biomedica

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Fresenius Medical Care AG & Co KGaA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Getinge AB

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 LivaNova Plc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Medtronic Plc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 MicroPort Scientific Corporation

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Nipro Medical Corporation

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Terumo Group

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Middle East & Africa ECMO Market

Analysis – by Modality (Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates)